Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/7/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Edward M. Sellers

Wrong Dr. Edward M. Sellers?

President

DL Global Partners Inc Professor Emeritus, Pharmacology, Medicine and Psychiatry at
Phone: (416) ***-****  HQ Phone
DL Global Partners Inc
Suite 100 78 Baby Point Cres.
Toronto , Ontario M6S 2C1
Canada

Company Description: DL Global Partners Inc. is an international consortium of consultants, key opinion leaders and services supporting drug and device development for disorders of the...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MD
  • PhD
  • University of Toronto
  • PhD.
  • M.D.
  • Ph.D.
  • Harvard University
  • Faculty of Medicine
134 Total References
Web References
Advisory Board « ElMindA
www.elminda.com, 7 Mar 2015 [cached]
Edward Sellers, M.D., Ph.D
Founder and President of DL Global Partners, and Professor Emeritus of Pharmacology, Medicine and Psychiatry at University of Toronto, Canada
DL Global Partners Inc. - Contact Us
www.dlglobalpartners.com, 9 July 2014 [cached]
Edward M. Sellers President and Principal DL Global Partners Inc. e.sellers@dlglobalpartners.com
Faculty Profiles
www.neuroscience.utoronto.ca, 15 Mar 2015 [cached]
Edward Sellers*
Dr. Ed Sellers, an ...
www.intellipharmaceutics.com, 28 Aug 2014 [cached]
Dr. Ed Sellers, an internationally recognized clinical pharmacologist and Professor Emeritus, University of Toronto, and President of DL Global Partners commented "The risk of overdose due to taking more opiate analgesic than prescribed is a real one.
DL Global Partners Inc. - About Us
www.dlglobalpartners.com, 9 July 2014 [cached]
Edward M. Sellers, MD, PhD, FRCPC, FACP President and Principal, DL Global Partners Inc.
An internationally recognized authority on clinical psychopharmacology, pharmacogenetics and smoking, abuse liability assessment and substance abuse. Dr. Sellers has been active in basic and applied science for over 40 years. During this time, he has published more than 350 peer reviewed papers and has been cited more than 23,000 times. He has a broad base of experience as an academic, hospital and CRO industry executive. During his career he has made not only pivotal scientific contributions but also, through his leadership and ability to problem solve, has been instrumental in successfully building programs, units and businesses. He is a founder of DecisionLine Clinical Research, Nicogen Inc. and ValleVista Natural Health Inc. As an independent consultant he has worked with academic institutions, hospitals, government agencies, investors and biopharmaceutical and device companies achieving a deep understanding of their needs. Areas of current focus include accelerating early stage drug development through new methods, optimizing strategies to assess abuse potential of new and re-formulated drugs and regulatory risk management and application of abuse liability methodology to modified risk tobacco related products.
After receiving his MD (Toronto 1965), PhD (Harvard 1971) and Internal Medicine specialty certification (1972), Dr. Sellers began his scientific career at the University of Toronto in 1972 and rapidly rose to the rank of full Professor as he established the world's foremost clinical psychopharmacology unit which trained many of today's leaders in the field. During this period he also became responsible for the operations of the Clinical Institute of the Addiction Research Foundation, one of the world's largest and best known research and treatment organizations in the substance abuse field. With increasingly senior appointments at the University of Toronto, for a period of five years he was responsible for all of the academic programs at the Faculty of Medicine University of Toronto.
In 1997, he co-founded and served as President and CEO of DecisionLine Clinical Research Corporation which grew to be a world leading early stage CRO focused on CNS drug development with over 80 beds and 220 employees until acquired in 2008 by Kendle International.
In 2010, he founded DL Global Partners Inc. He sits on numerous Scientific Advisory Boards of pharmaceutical and device companies and recently chaired the Scientific Advisory Panel on Opiate Analgesic Abuse for the Therapeutic Products Directorate, Health Canada.
Dr. Sellers has received numerous awards including the Rawls Palmer Progress in Medicine Award (1987 ASCPT); Nathan B. Eddy Award 2012 CPDD; Oscar B Hunter Award (2014 ASCPT).
Other People with the name "Sellers":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304